We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+6.38%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$37.1B
AUM Growth
+$1.81B
(+5.1%)
Cap. Flow
-$137M
Cap. Flow
% of AUM
-0.37%
Top 10 Holdings %
Top 10 Hldgs %
8.75%
Holding
2,506
New
326
Increased
944
Reduced
921
Closed
286
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PG&E
PCG
|
+$297M |
| 2 |
CELG
Celgene Corp
CELG
|
+$277M |
| 3 |
US Bancorp
USB
|
+$190M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$154M |
| 5 |
ExxonMobil
XOM
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$259M |
| 2 |
DuPont de Nemours
DD
|
+$255M |
| 3 |
Boeing
BA
|
+$243M |
| 4 |
Altria Group
MO
|
+$234M |
| 5 |
Union Pacific
UNP
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.5% |
| 2 | Technology | 15.03% |
| 3 | Consumer Discretionary | 14.19% |
| 4 | Industrials | 12.34% |
| 5 | Consumer Staples | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Celldex Therapeutics
CLDX
$2.77B
| $238K | ﹤0.01% |
+5,590
| New | +$239K |
|
|
SBOW
2027
DELISTED
SilverBow Resources, Inc.
SBOW
| $238K | ﹤0.01% |
+8,000
| New | +$187K |
|
2028
Century Casinos
CNTY
$32.9M
| $237K | ﹤0.01% |
+26,000
| New | +$226K |
|
|
JAX
2029
DELISTED
J. Alexander's Holdings, Inc.
JAX
| $237K | ﹤0.01% |
24,400
-100
| -0.4% | -$1.04K |
|
|
ADVM
2030
DELISTED
Adverum Biotechnologies
ADVM
| $236K | ﹤0.01% |
+6,750
| New | +$222K |
|
|
BLD
2031
DELISTED
TopBuild
BLD
| $236K | ﹤0.01% |
3,111
-13,100
| -81% | -$869K |
|
|
AMAG
2032
DELISTED
AMAG Pharmaceuticals
AMAG
| $236K | ﹤0.01% |
17,800
-9,500
| -35% | -$143K |
|
|
TIME
2033
DELISTED
Time Inc.
TIME
| $236K | ﹤0.01% |
+12,815
| New | +$192K |
|
2034
J&J Snack Foods
JJSF
$1.43B
| $235K | ﹤0.01% |
+1,551
| New | +$218K |
|
|
IPCC
2035
DELISTED
Infinity Property & Casualty C
IPCC
| $234K | ﹤0.01% |
2,204
| – | – |
|
2036
Selective Insurance
SIGI
$5.74B
| $233K | ﹤0.01% |
+3,964
| New | +$229K |
|
|
EV
2037
DELISTED
Eaton Vance Corp.
EV
| $233K | ﹤0.01% |
+4,130
| New | +$219K |
|
2038
Curis
CRIS
$9.53M
| $232K | ﹤0.01% |
166
+156
| +1,560% | +$367K |
|
2039
Verastem
VSTM
$532M
| $231K | ﹤0.01% |
+6,283
| New | +$284K |
|
|
AAT
2040
American Assets Trust
AAT
$1.49B
| $230K | ﹤0.01% |
6,008
+100
| +2% | +$3.93K |
|
2041
Aon
AON
$77.3B
| $230K | ﹤0.01% |
+1,718
| New | +$245K |
|
2042
International Paper
IP
$22.3B
| $230K | ﹤0.01% |
4,193
-274,983
| -98% | -$14.8M |
|
2043
VEON
VEON
$3.53B
| $230K | ﹤0.01% |
+2,396
| New | +$234K |
|
2044
Farmers National Banc Corp
FMNB
$899M
| $227K | ﹤0.01% |
15,400
| – | – |
|
2045
Griffon
GFF
$4.16B
| $227K | ﹤0.01% |
11,136
-700
| -6% | -$15.3K |
|
|
FFNW
2046
DELISTED
First Financial Northwest, Inc
FFNW
| $226K | ﹤0.01% |
14,543
-5,600
| -28% | -$93.1K |
|
|
NNA
2047
DELISTED
Navios Maritime Acquisition Corporation
NNA
| $226K | ﹤0.01% |
13,600
-1,227
| -8% | -$23.1K |
|
2048
Steven Madden
SHOO
$3.12B
| $225K | ﹤0.01% |
7,218
-3,900
| -35% | -$109K |
|
2049
Cavco Industries
CVCO
$4.39B
| $224K | ﹤0.01% |
1,470
-300
| -17% | -$45.1K |
|
2050
Deluxe
DLX
$1.19B
| $224K | ﹤0.01% |
2,915
-5,100
| -64% | -$368K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, Two Sigma Advisers held 2,506 positions worth $37.1B, up 5.1% from $35.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Two Sigma Advisers's Q4 2017 filing shows 326 new, 944 increased, 921 reduced and 286 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 381,038 shares worth $143M. The largest sale was Chevron, an estimated $259M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
- Two Sigma Advisers's largest Q4 2017 buy was Regeneron Pharmaceuticals: 381,038 shares worth $143M.
- Two Sigma Advisers added most to PG&E in Q4 2017, an estimated $297M increase.
- Two Sigma Advisers's biggest Q4 2017 reduction was Chevron, cutting an estimated $259M.
- Two Sigma Advisers fully exited DuPont de Nemours in Q4 2017, selling an estimated $255M.
- Two Sigma Advisers's ten largest holdings make up 8.7% of its $37.1B portfolio in Q4 2017.
- Two Sigma Advisers opened 326 new positions and closed 286 in Q4 2017.
- Two Sigma Advisers's portfolio value rose 5.1% quarter-over-quarter to $37.1B.
Based on Two Sigma Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.